A Study of BCMA-directed CAR-T Cells Treatment in Subjects With r/r Multiple Myeloma
Clinical trial NCT03815383 · UNKNOWN
Trial details
- NCT number
- NCT03815383
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-11
- Primary completion
- 2021-01-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.